Rx Pak Division of McKesson Corporation recalls Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by:
Rx Pak recalls Docusate Sodium 100mg softgels due to label mix-up with Gabapentin 300mg. Institutional users should check packaging for correct labeling to avoid confusion.
Lower-risk recall
Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.
Contact the company & request your remedy
What happened, in plain English
Rx Pak is recalling Docusate Sodium 100mg softgels that may have incorrect labels showing Gabapentin 300mg instead of Docusate Sodium. This could lead to confusion and potential misuse if institutional users mix up the products. Read more at govinfonow.com/recall/39239-rx-pak-docusate-sodium-100mg-softgels-recall-label-mix-up.
Source Summary by GovInfoNow · govinfonow.com/recall/39239-rx-pak-docusate-sodium-100mg-softgels-recall-label-mix-up · Updated October 5, 2026 · FDA enforcement record: FDA #D-1007-2019
Cite this page
“Rx Pak Docusate Sodium 100mg Softgels Recall: Label Mix-Up Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39239-rx-pak-docusate-sodium-100mg-softgels-recall-label-mix-up. Based on FDA recall #D-1007-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1007-2019%22&limit=1).
Why it’s dangerous
The secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgels. This mix-up could cause confusion in institutional settings where multiple medications are used, potentially leading to incorrect administration.
Who’s affected
Institutional users who have the Docusate Sodium 100mg softgels in 10 x 10 blister packs. Those most at risk are healthcare facilities handling medications without proper verification.
How to tell if you have this one
Check the secondary carton label for 'Docusate Sodium 100mg softgel caps' instead of 'Gabapentin 300mg'. The product was manufactured by Aenova Holding GmBh in Miami, Florida with NDC 63739-0478-10.
- Brand
Rx Pak- Category
Drug
What to do — step by step
Check Label
Verify the secondary carton label shows 'Docusate Sodium 100mg softgel caps' not 'Gabapentin 300mg'.
Questions people ask
Is this product safe to use?
The product is safe if the label is correctly identified as Docusate Sodium 100mg softgels. Incorrect labeling could lead to confusion in institutional settings.
Who should be concerned about this recall?
Institutional users, such as healthcare facilities that handle medications, should check their stock for correct labeling.
How can I tell if I have the recalled product?
Look for the secondary carton labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgels. The product was manufactured by Aenova Holding GmBh in Miami, Florida with NDC 63739-0478-10.
Contact Rx Pak
We’ve drafted a message you can send Rx Pak to request your refund or repair — edit it as you like.
Subject: Recall D-1007-2019 — Rx Pak Rx Pak Hello, I own a Rx Pak that is covered by recall D-1007-2019 from Rx Pak. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1007-2019 (January 16, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1007-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.